SE384856B - Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan - Google Patents
Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkanInfo
- Publication number
- SE384856B SE384856B SE7214215A SE1421572A SE384856B SE 384856 B SE384856 B SE 384856B SE 7214215 A SE7214215 A SE 7214215A SE 1421572 A SE1421572 A SE 1421572A SE 384856 B SE384856 B SE 384856B
- Authority
- SE
- Sweden
- Prior art keywords
- analgetic
- inflammatory
- way
- antipyretic effects
- preparing content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1811672A GB1356834A (en) | 1971-11-03 | 1971-11-03 | Indole derivatives |
GB1811672 | 1972-04-19 | ||
GB3076772 | 1972-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE384856B true SE384856B (sv) | 1976-05-24 |
Family
ID=27257588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7214215A SE384856B (sv) | 1971-11-03 | 1972-11-02 | Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan |
Country Status (17)
Country | Link |
---|---|
US (1) | US3884919A (xx) |
JP (1) | JPS4856667A (xx) |
AR (3) | AR198064A1 (xx) |
BE (1) | BE790679A (xx) |
CA (1) | CA983932A (xx) |
CH (1) | CH577499A5 (xx) |
DD (1) | DD105611A5 (xx) |
DE (1) | DE2253927A1 (xx) |
EG (1) | EG11358A (xx) |
ES (2) | ES408226A1 (xx) |
FR (1) | FR2158464B1 (xx) |
GB (1) | GB1356834A (xx) |
HU (1) | HU169711B (xx) |
IE (1) | IE37998B1 (xx) |
IL (1) | IL40521A (xx) |
NL (1) | NL7214807A (xx) |
SE (1) | SE384856B (xx) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022780A (en) * | 1973-03-06 | 1977-05-10 | Imperial Chemical Industries Limited | Process for the manufacture of indole derivatives |
FR2421900A1 (fr) * | 1977-03-17 | 1979-11-02 | Sauba Lab | Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques |
US4316847A (en) * | 1979-07-30 | 1982-02-23 | Hoffmann-La Roche Inc. | Pyrroles and pyrrolidines |
US4459227A (en) * | 1981-03-02 | 1984-07-10 | Duke University | Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones |
EP0746554A1 (en) * | 1994-02-23 | 1996-12-11 | Pfizer Inc. | 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
US6252084B1 (en) * | 1994-03-15 | 2001-06-26 | Eli Lilly And Company | 1H-indole-3-acetamide sPLA2 inhibitors |
IL137719A0 (en) * | 1998-02-25 | 2001-10-31 | Genetics Inst | Inhibitors of phospholipase enzymes |
US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
SE0200411D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
SE0200356D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
SE0301009D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
PT1471057E (pt) | 2003-04-25 | 2006-05-31 | Actimis Pharmaceuticals Inc | Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2 |
ES2290743T3 (es) * | 2003-04-30 | 2008-02-16 | The Institutes For Pharmaceutical Discovery, Llc | Heteroarilos sustituidos como inhibidores de las proteina-tirosina fosfatasas. |
SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
PT1718649E (pt) | 2004-01-31 | 2009-08-06 | Actimis Pharmaceuticals Inc | Derivados de ácido imidazo[1,2-c]pirimidinilacético |
GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
WO2006056752A1 (en) | 2004-11-23 | 2006-06-01 | Astrazeneca Ab | Phenoxyacetic acid derivatives useful for treating respiratory diseases |
GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
JP5155171B2 (ja) | 2005-10-06 | 2013-02-27 | アストラゼネカ・アクチエボラーグ | 新規化合物 |
JP2009538289A (ja) | 2006-05-26 | 2009-11-05 | アストラゼネカ・アクチエボラーグ | ビアリールまたはヘテロアリール置換インドール |
PL2046740T3 (pl) | 2006-07-22 | 2012-10-31 | Oxagen Ltd | Związki o aktywności antagonisty CRTH2 |
UA100983C2 (xx) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Біфенілоксипропанова кислота як модулятор crth2 і інтермедіати$бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
SI2205569T1 (sl) | 2007-09-25 | 2012-06-29 | Actimis Pharmaceuticals Inc | Alkiltio pirimidini kot crth2 antagonisti |
CN101874024A (zh) | 2007-09-25 | 2010-10-27 | 艾克提麦斯医药品有限公司 | 作为crth2拮抗剂的2-s-苄基取代的嘧啶 |
US7750027B2 (en) | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
MX2010007833A (es) | 2008-01-18 | 2010-08-11 | Oxagen Ltd | Compuestos que tienen actividad antagonista de crth2. |
JP2011509991A (ja) | 2008-01-22 | 2011-03-31 | オキサジェン リミテッド | Crth2アンタゴニスト活性を有する化合物 |
WO2009093026A1 (en) | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
CN113164761A (zh) * | 2018-10-05 | 2021-07-23 | 弗特克斯药品有限公司 | α-1抗胰蛋白酶的调节剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL125443C (xx) * | 1963-06-06 | |||
US3679692A (en) * | 1969-10-01 | 1972-07-25 | Mead Johnson & Co | Iminomethylindolines |
-
0
- BE BE790679D patent/BE790679A/xx unknown
-
1971
- 1971-11-03 GB GB1811672A patent/GB1356834A/en not_active Expired
-
1972
- 1972-09-28 IE IE1320/72A patent/IE37998B1/xx unknown
- 1972-09-29 CA CA152,944A patent/CA983932A/en not_active Expired
- 1972-10-06 IL IL40521A patent/IL40521A/xx unknown
- 1972-10-10 US US296202A patent/US3884919A/en not_active Expired - Lifetime
- 1972-10-27 AR AR244863A patent/AR198064A1/es active
- 1972-10-29 EG EG446/72A patent/EG11358A/xx active
- 1972-11-02 JP JP47110172A patent/JPS4856667A/ja active Pending
- 1972-11-02 DD DD166646A patent/DD105611A5/xx unknown
- 1972-11-02 FR FR7238836A patent/FR2158464B1/fr not_active Expired
- 1972-11-02 SE SE7214215A patent/SE384856B/xx unknown
- 1972-11-02 CH CH1597672A patent/CH577499A5/xx unknown
- 1972-11-02 NL NL7214807A patent/NL7214807A/xx unknown
- 1972-11-03 DE DE2253927A patent/DE2253927A1/de active Pending
- 1972-11-03 ES ES408226A patent/ES408226A1/es not_active Expired
- 1972-11-03 HU HUIE540A patent/HU169711B/hu unknown
-
1973
- 1973-07-31 AR AR249381A patent/AR203626A1/es active
- 1973-07-31 AR AR249382A patent/AR203627A1/es active
-
1975
- 1975-04-30 ES ES437331A patent/ES437311A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AR198064A1 (es) | 1974-05-31 |
CA983932A (en) | 1976-02-17 |
BE790679A (fr) | 1973-04-27 |
DD105611A5 (xx) | 1974-05-05 |
US3884919A (en) | 1975-05-20 |
FR2158464A1 (xx) | 1973-06-15 |
AR203626A1 (es) | 1975-09-30 |
HU169711B (xx) | 1977-02-28 |
EG11358A (en) | 1977-02-28 |
NL7214807A (xx) | 1973-05-07 |
IE37998L (en) | 1973-05-03 |
AR203627A1 (es) | 1975-09-30 |
IL40521A0 (en) | 1972-12-29 |
CH577499A5 (xx) | 1976-07-15 |
IL40521A (en) | 1975-06-25 |
FR2158464B1 (xx) | 1976-07-02 |
DE2253927A1 (de) | 1973-05-10 |
JPS4856667A (xx) | 1973-08-09 |
ES408226A1 (es) | 1976-02-01 |
IE37998B1 (en) | 1977-12-07 |
GB1356834A (en) | 1974-06-19 |
ES437311A1 (es) | 1977-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE384856B (sv) | Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan | |
FI55379B (fi) | Polyolefinmassa med baettre vattenavledningsegenskaper foer framstaellning av papper och massans framstaellningsfoerfarande | |
SE7602339L (sv) | Kinolonderivat och sett att framstella desamma | |
SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
SE7605925L (sv) | Nya prostanderivat och sett att framstella desamma | |
SE405599B (sv) | Forfarande for framstellning av pyridazinoner med terapeutisk verkan | |
SE402283B (sv) | Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan | |
SE406197B (sv) | Analogiforfarande for framstellning av 4-aminokinazolinderivat | |
SE7508544L (sv) | Bensimidazol-derivat och sett att framstella desamma. | |
BE786155A (fr) | Derives heterocycliques n-substitues ainsi que leur preparation | |
SE397523B (sv) | Forfarande att framstella n-fenylpyrrolderivat med antiinflammatorisk och analgetisk verkan | |
FI54592C (fi) | Foerpackning av straengar av med adhesionsmedel belagda glasfibrer och foerfarande foer framstaellning av foerpackningen | |
FI56100B (fi) | Loesningskoncentrat med fungicid och acaricid verkan | |
SE395892B (sv) | Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan | |
SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
SE399069B (sv) | Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat | |
SE385896B (sv) | Forfarande for framstellning av 2,3-dihydro-4h-tieno-(3,2-c)(1)bensopyran-4-oner med analgetisk och antipyretisk verkan | |
SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
SE401829B (sv) | Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav | |
FI53790B (fi) | Foerfarande och anordning foer styrd gjutning av en form med smaelt metall | |
SE394680B (sv) | Forfarande for framstellning av cykliska fosfamidderivat | |
SE409866B (sv) | Forfarande for framstellning av adenosinderivat | |
SE405730B (sv) | Forfarande for framstellning av kinazolinderivat | |
SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat |